| Ref.No: | 61519400 |
| Start date: | 03.11.2025 |
| End date: | 02.11.2029 |
| Approval date: | 29.10.2025 |
| Department: | APPLIED MATHEMATICAL & PHYSICAL SCIENCES |
| Sector: | PHYSICS |
| Financier: | 3Η ΠΡΟΚΗΡΥΞΗ ΕΛΙΔΕΚ ΓΙΑ ΜΕΛΗ ΔΕΠ&ΕΡΕΥΝΗΤΕΣ, ELIDEK |
| Budget: | 281.971,00 € |
| Public key: | Ψ1ΑΙ46ΨΖΣ4-33Σ |
| Scientific Responsible: | Prof. ZERGIOTI |
| Email: | zergioti@central.ntua.gr |
| Description: | CARTILAGE, LACKING BLOOD VESSELS AND SELF-REGENERATION CAPABILITIES, FACES CHALLENGES IN TREATMENT OPTIONS. CURRENT APPROACHES FOCUS ON SYMPTOM RELIEF, AND SURGERY BECOMES NECESSARY AS CONDITIONS WORSEN. BIOPRINTING TECHNOLOGIES SHOW PROMISE IN TISSUE ENGINEERING, YET SLOW CLINICAL TRANSLATION PERSISTS DUE TO THE LACK OF QUALITY CONTROL AND STANDARDIZATION. THIS PROJECT AIMS TO REVOLUTIONIZE MEDICAL ENGINEERING BY DEVELOPING A LASER PRINTING TOOL FOR ENDOSCOPIC USE, COMBINING MODULES FOR CELL TRANSFER AND MATRIX DEVELOPMENT. THE INNOVATION LIES IN ADAPTING TISSUE CREATION TO INDIVIDUAL ANATOMICAL NEEDS, ENHANCING TOOL ADAPTABILITY AND EFFICACY. THIS CUSTOMIZATION POTENTIAL BENEFITS MINIMALLY INVASIVE SURGERIES, IMPROVING OUTCOMES AND REDUCING RECOVERY TIMES. THE TECHNOLOGY OFFERS A COST-EFFECTIVE SOLUTION BY STREAMLINING PRODUCTION AND MINIMIZING WASTE, CONTRIBUTING TO THE EVOLUTION OF PERSONALIZED HEALTHCARE. THE CARDILAS PROJECT EXPLORES NOVEL APPROACHES, INCLUDING PRINTING HUMAN CHONDROCYTES AND MESENCHYMAL STEM CELLS WITHIN HYDROGEL MATRIXES OR DIRECTLY AT THE DAMAGED TISSUE (IN VIVO). |
